Task: Please answer the following question about the molecule with SMILES C[C@](N)(Cc1ccc(O)cc1)C(=O)O.
Description: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
C[C@](N)(Cc1ccc(O)cc1)C(=O)O
C[C@](N)(Cc1ccc(O)cc1)C(=O)O
(2S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.